DOLBY LABORATORIES, INC. (DLB) Total liabilities 2016–2025
DOLBY LABORATORIES, INC. (DLB) total liabilities at each fiscal year-end, per SEC filings.
$595.8MFY2025 · since FY2016: $331.4M → $595.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $595.8M | -4.4% |
| FY2024 | $623.0M | +2.5% |
| FY2023 | $607.6M | +38.6% |
| FY2022 | $438.5M | -12.5% |
| FY2021 | $501.5M | +4.7% |
| FY2020 | $478.9M | -5.9% |
| FY2019 | $508.7M | +2.8% |
| FY2018 | $494.9M | +27.0% |
| FY2017 | $389.7M | +17.6% |
| FY2016 | $331.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice